Recent Patents on Anti-Infective Drug Discovery
Volume 15, 3 Issues, 2020
ISSN: 2212-4071 (Online)
ISSN: 1574-891X (Print)
This journal supports open access
ISSN: 2212-4071 (Online)
ISSN: 1574-891X (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Recent Patents on Anti-Infective Drug Discovery, Volume 8 - Number 1
Climate Change, Climate Variability and Brucellosis
, 8(1): 4 - 12Alfonso J. Rodriguez-Morales
DOI: 10.2174/1574891X11308010003
Immunopathology of Brucella Infection
, 8(1): 18 - 26Pablo C. Baldi and Guillermo H. Giambartolomei
DOI: 10.2174/1574891X11308010005
Brucella as a Potential Agent of Bioterrorism
, 8(1): 27 - 33Gizem D. Doganay and Mehmet Doganay
DOI: 10.2174/1574891X11308010006
Clinical Presentations and Diagnosis of Brucellosis
, 8(1): 34 - 41Aysegul Ulu Kilic, Gokhan Metan and Emine Alp
DOI: 10.2174/1574891X11308010007
Update on Childhood Brucellosis
, 8(1): 42 - 46Mohammad R.H. Roushan and Mohammad J.S. Amiri
DOI: 10.2174/1574891X11308010008
Pregnancy Associated Brucellosis
, 8(1): 47 - 50Jaffar A. Al-Tawfiq and Ziad A Memish
DOI: 10.2174/1574891X11308010009
Antibiotic Susceptibility and Treatment of Brucellosis
, 8(1): 51 - 54Jaffar A. Al-Tawfiq and Ziad A Memish
DOI: 10.2174/1574891X11308010010
Update On Emerging Antivirals For The Management Of Herpes Simplex Virus Infections: A Patenting Perspective
, 8(1): 55 - 67Aswani D. Vadlapudi, Ramya K. Vadlapatla and Ashim K. Mitra
DOI: 10.2174/1574891X11308010011
Bacterial Quorum Sensing Inhibitors: Attractive Alternatives for Control of Infectious Pathogens Showing Multiple Drug Resistance
, 8(1): 68 - 83Ashima K. Bhardwaj, Kittappa Vinothkumar and Neha Rajpara
DOI: 10.2174/1574891X11308010012
Editor-in-Chief
Tianhong Dai
Massachusetts General Hospital
Harvard Medical School
Boston, MA
(USA)
Biography
Massachusetts General Hospital
Harvard Medical School
Boston, MA
Biography
Biography of Tianhong Dai
Tianhong Dai is an assistant professor with the Harvard Medical School. He is considered a world leader in antimicrobial blue light therapy for infections, and a world expert in animal models of wound infections using bioluminescent microbes. He is the author and co-author of more than 80 peer-reviewed publications. Dr. Dai’s research has been supported by the NIH (R01 and R21), DoD and other funding sources.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Recent Patents on Anti-Infective Drug Discovery was launched in 2006. Dr. Tianhong Dai serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.10
New eBook
 |
Frontiers in Clinical Drug Research-Anti InfectivesYou can view the contents of this eBook [here] or purchase it [here]. |
Advertisement
Webmaster Contact: info@benthamscience.net